Endo To Become The Next Valeant - Or Part Of Valeant

February 26, 2013, 7:14 am

≫ Next: Valeant Earnings Seen Rising As Firm Digests Medicis

$

0

0

Endo To Become The Next Valeant - Or Part Of Valeant

Seeking Alpha

---

Valeant Earnings Seen Rising As Firm Digests Medicis

February 28, 2013, 7:55 am

≫ Next: New CEO From Valeant May Mean Endo Takeover Imminent

≪ Previous: Endo To Become The Next Valeant - Or Part Of Valeant

$

0

0

Valeant Earnings Seen Rising As Firm Digests Medicis

Investors.com

New CEO From Valeant May Mean Endo Takeover Imminent

March 7, 2013, 8:38 am

≫ Next: Valeant Buying Obagi Medical; Both Stocks Jump By AMY REEVES, INVESTOR'S BUSINESS DAILY

≪ Previous: Valeant Earnings Seen Rising As Firm Digests Medicis

$

0

0

New CEO From Valeant May Mean Endo Takeover Imminent

Seeking Alpha

Valeant Buying Obagi Medical; Both Stocks Jump By AMY REEVES, INVESTOR'S BUSINESS DAILY

March 20, 2013, 9:23 am

≫ Next: Valeant Pharmaceuticals Receives “Buy” Rating from Jefferies Group (VRX)

≪ Previous: New CEO From Valeant May Mean Endo Takeover Imminent

$

0

0

Valeant Buying Obagi Medical; Both Stocks Jump

Investors.com

Valeant Pharmaceuticals Receives “Buy” Rating from Jefferies Group (VRX)

March 23, 2013, 7:01 am

≫ Next: Obagi Medical Sued by Investor Over $360 Million Offer

≪ Previous: Valeant Buying Obagi Medical; Both Stocks Jump By AMY REEVES, INVESTOR'S BUSINESS DAILY

$

0

0

Valeant Pharmaceuticals Receives “Buy” Rating from Jefferies Group (VRX)

Zolmax

Obagi Medical Sued by Investor Over $360 Million Offer

March 25, 2013, 9:16 am

≫ Next: Obagi Medical gets higher offer from Merz Pharma

≪ Previous: Valeant Pharmaceuticals Receives “Buy” Rating from Jefferies Group (VRX)

$

0

0

Obagi Medical Sued by Investor Over $360 Million Offer

Bloomberg

Obagi Medical gets higher offer from Merz Pharma

April 2, 2013, 7:53 am

≫ Next: Most Profitable Second Quarter Biotech Stocks

≪ Previous: Obagi Medical Sued by Investor Over $360 Million Offer

$

0

0

Obagi Medical gets higher offer from Merz Pharma

Reuters

Most Profitable Second Quarter Biotech Stocks

April 2, 2013, 7:58 am

≫ Next: Valeant sweetens bid for Obagi Medical

≪ Previous: Obagi Medical gets higher offer from Merz Pharma

$

0

0

Most Profitable Second Quarter Biotech Stocks

TheStreet.com

---

Valeant sweetens bid for Obagi Medical

April 3, 2013, 5:46 am

≫ Next: Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

≪ Previous: Most Profitable Second Quarter Biotech Stocks

$

0

0

Valeant sweetens bid for Obagi Medical

Reuters

Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

April 5, 2013, 8:08 am

≫ Next: Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

≪ Previous: Valeant sweetens bid for Obagi Medical

$

0

0

Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

Bloomberg

Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

April 6, 2013, 7:46 am

≫ Next: Merz Pharma drops out of race for Obagi Medical

≪ Previous: Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

$

0

0

Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

Bloomberg

Merz Pharma drops out of race for Obagi Medical

April 8, 2013, 8:31 am

≫ Next: Mylan rains on Valeant parade with Zovirax generic

≪ Previous: Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

$

0

0

Merz Pharma drops out of race for Obagi Medical

Reuters

Mylan rains on Valeant parade with Zovirax generic

April 8, 2013, 8:57 am

≫ Next: Valeant, Actavis team up on two more authorized generics

≪ Previous: Merz Pharma drops out of race for Obagi Medical

$

0

0

Mylan rains on Valeant parade with Zovirax generic

Fierce Pharma

Valeant, Actavis team up on two more authorized generics

April 11, 2013, 9:37 am

≫ Next: Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara

≪ Previous: Mylan rains on Valeant parade with Zovirax generic

$

0

0

Valeant, Actavis team up on two more authorized generics

Fierce Pharma

Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara

April 13, 2013, 9:27 am

≫ Next: 4 Stocks Pushing The Drugs Industry Downward

≪ Previous: Valeant, Actavis team up on two more authorized generics

$

0

0

Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara

Pharmabiz

---

4 Stocks Pushing The Drugs Industry Downward

April 22, 2013, 11:05 am

≫ Next: Valeant completes tender offer for Obagi Medical

≪ Previous: Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara

$

0

0

4 Stocks Pushing The Drugs Industry Downward

TheStreet.com

Valeant completes tender offer for Obagi Medical

April 25, 2013, 7:45 am

≫ Next: Valeant Pharmaceuticals in Talks to Buy Actavis

≪ Previous: 4 Stocks Pushing The Drugs Industry Downward

$

0

0

Valeant completes tender offer for Obagi Medical

Yahoo/Fly on the Wall

Valeant Pharmaceuticals in Talks to Buy Actavis

April 27, 2013, 8:05 am

≫ Next: On verge of $13B merger, Valeant and Actavis stop talking

≪ Previous: Valeant completes tender offer for Obagi Medical

$

0

0

Valeant Pharmaceuticals in Talks to Buy Actavis

Wall Street Journal

On verge of $13B merger, Valeant and Actavis stop talking

April 30, 2013, 6:47 am

≫ Next: 2013 FDA Drug Approval Calendar

≪ Previous: Valeant Pharmaceuticals in Talks to Buy Actavis

$

0

0

On verge of $13B merger, Valeant and Actavis stop talking

Fierce Pharma

2013 FDA Drug Approval Calendar

May 21, 2013, 9:05 am

≫ Next: Valeant Reportedly Nearing Deal To Buy Bausch & Lomb For $9 Bln

≪ Previous: On verge of $13B merger, Valeant and Actavis stop talking

$

0

0

2013 FDA Drug Approval Calendar

TheStreet.com